Results 151 to 160 of about 6,313 (203)

Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli-D Study. [PDF]

J Diabetes
Wu X, Zhang Y, Li Z, Alvarez A, Lauand F, Melas-Melt L, Zhang M, Kang L, Du Q, Zhang J, Mu Y.   +10 more
europepmc   +1 more source

Ferroptosis and pyroptosis in diabetes mellitus: emerging therapeutic potential of GLP-1 receptor agonists. [PDF]

Front Clin Diabetes Healthc
Panou T, Gouveri E, Rizzo M, Popovic DS, Papanas N.   +4 more
europepmc   +1 more source

An overview of randomized clinical trials of fixed-ratio combinations of basal insulin plus GLP-1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes. [PDF]

Diabetes Obes Metab
Bolli GB, Porcellati F, Lucidi P, Fanelli CG, Perseghin G, Horowitz M, Owens DR.   +6 more
europepmc   +1 more source

Efficacy and Hypoglycemia Profile of Once-weekly Insulin Icodec vs Once-daily Comparators Across Demographic Subgroups.

J Clin Endocrinol Metab
Lingvay I, Bache JK, Desouza CV, Fragão-Marques M, Navarria A, Shaikh SS, Vianna AGD.   +6 more
europepmc   +1 more source

Blood glucose variability in early-onset adrenocorticotropic hormone deficiency induced by immune checkpoint inhibitor therapy with continuous blood glucose monitoring: a case report. [PDF]

Diabetol Int
Nanao Y, Egusa G, Baba R, Kodama T, Matsuda T, Nagano G, Ohno H.   +6 more
europepmc   +1 more source

Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus. [PDF]

Rev Endocr Metab Disord
Pham DQ, Andraos J, Ayoub J.
europepmc   +1 more source

Degludec – une nouvelle insuline retard

Forum Médical Suisse ‒ Swiss Medical Forum, 2013
openaire   +1 more source

No evidence of increased hypoglycaemia attributed to physical activity with once-weekly insulin icodec versus once-daily basal insulin degludec in type 1 diabetes: A post hoc analysis of ONWARDS 6. [PDF]

Diabetes Obes Metab
Sourij H, Bracken RM, Carstensen L, Pagliaro Rocha TM, Kehlet Watt S, Philis-Tsimikas A.   +5 more
europepmc   +1 more source

Degludec – Ein neues langwirkendes Insulin

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2013
openaire   +1 more source

Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist and sodium-glucose co-transporter-2 inhibitor use: A post hoc analysis of ONWARDS 1-5. [PDF]

Diabetes Obes Metab
Vilsbøll T, Fu A, Kellerer M, Kumar B, Søgaard SB, Goldenberg R.   +5 more
europepmc   +1 more source